News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,369 Results
Type
Article (42067)
Company Profile (295)
Press Release (668007)
Section
Business (210245)
Career Advice (2086)
Deals (36607)
Drug Delivery (100)
Drug Development (82914)
Employer Resources (172)
FDA (16518)
Job Trends (15372)
News (355646)
Policy (33848)
Tag
Academia (2574)
Alliances (51288)
Alzheimer's disease (1317)
Approvals (16482)
Artificial intelligence (193)
Bankruptcy (364)
Best Places to Work (11754)
Biotechnology (188)
Breast cancer (217)
Cancer (1617)
Cardiovascular disease (129)
Career advice (1744)
CAR-T (113)
Cell therapy (326)
Clinical research (66588)
Collaboration (622)
Compensation (317)
COVID-19 (2627)
C-suite (144)
Data (1521)
Diabetes (197)
Diagnostics (6318)
Earnings (86814)
Employer resources (149)
Events (113385)
Executive appointments (529)
FDA (17347)
Funding (555)
Gene therapy (235)
GLP-1 (669)
Government (4469)
Healthcare (18924)
Infectious disease (2725)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16698)
Job creations (4053)
Job search strategy (1489)
Layoffs (452)
Legal (8344)
Lung cancer (236)
Manufacturing (231)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (20206)
Metabolic disorders (533)
Neuroscience (1709)
NextGen: Class of 2025 (6632)
Non-profit (4521)
Northern California (1931)
Obesity (305)
Opinion (213)
Patents (142)
People (58678)
Phase I (20642)
Phase II (29299)
Phase III (21958)
Pipeline (641)
Postmarket research (2653)
Preclinical (8744)
Radiopharmaceuticals (245)
Rare diseases (313)
Real estate (6245)
Regulatory (22683)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1672)
Startups (3718)
United States (17416)
Vaccines (609)
Weight loss (216)
Date
Today (19)
Last 7 days (632)
Last 30 days (2674)
Last 365 days (35199)
2025 (2698)
2024 (35770)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33138)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (213)
Asia (40309)
Australia (6455)
California (4428)
Canada (1610)
China (378)
Colorado (201)
Connecticut (211)
Europe (85847)
Florida (636)
Georgia (154)
Illinois (442)
Indiana (257)
Maryland (706)
Massachusetts (3446)
Michigan (190)
Minnesota (323)
New Jersey (1259)
New York (1272)
North Carolina (817)
Northern California (1931)
Ohio (161)
Pennsylvania (1032)
South America (1159)
Southern California (1672)
Texas (653)
Utah (130)
Washington State (442)
710,369 Results for "agios pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio
January 14, 2025
·
11 min read
Genetown
Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, announced that the company has agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma.
May 28, 2024
·
6 min read
Genetown
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, announced that data from its programs will be presented at the European Hematology Association 2024 Hybrid Congress, to be held June 13-16, 2024, in Madrid, Spain.
May 14, 2024
·
8 min read
Genetown
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. ET.
May 3, 2024
·
1 min read
Drug Development
Agios Blood Disorder Drug Scores Another Phase III Win
Agios Pharmaceuticals’ Pyrukynd met both the primary and secondary endpoints in patients with transfusion-dependent alpha- or beta-thalassemia.
June 3, 2024
·
2 min read
·
Tyler Patchen
Genetown
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
Agios Pharmaceuticals, Inc. today announced that the company is scheduled to present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 1:20 p.m. ET.
May 30, 2024
·
1 min read
Business
Agios Reports Business Highlights and First Quarter 2024 Financial Results
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, reported business highlights and financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
10 min read
Press Releases
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
January 3, 2025
·
1 min read
Genetown
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, announced that the company is scheduled to present at the BofA Securities 2024 Health Care Conference on Thursday, May 16, 2024, at 11:40 a.m. ET.
May 6, 2024
·
1 min read
Genetown
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
Agios Pharmaceuticals, Inc. today announced the company will host a conference call and live webcast on Thursday, May 2, 2024, at 8:00 a.m. ET to report its first quarter 2024 financial results and other business highlights.
April 18, 2024
·
1 min read
1 of 71,037
Next
